Angela Yang | Health Professions | Innovative Research Award

Published on by Award and Honors

Innovative Research Award

Angela Yang
Affiliation RMIT University
Country Australia
Scopus ID 24598325800
Documents 66
Citations 1,491
h-index 20
Subject Area Health Professions
Event Award and Honors
ORCID 0000-0001-9345-4607

Angela Yang
RMIT University, Australia

Angela Yang is a researcher affiliated with RMIT University whose scholarly activities contribute to the field of Health Professions through interdisciplinary research, evidence-informed practice, and academic collaboration. Her publication record demonstrates continued engagement with peer-reviewed research and international scientific communication. With an established citation profile, measurable research impact, and sustained publication output, her work reflects a commitment to advancing knowledge that supports healthcare education and professional practice. These academic achievements provide a suitable basis for consideration within the Innovative Research Award under the Award and Honors event.[1]

Abstract

Angela Yang has established an academic profile characterized by peer-reviewed publications, measurable citation performance, and interdisciplinary collaboration within Health Professions. Her research emphasizes scientific rigor, evidence-based methodologies, and practical relevance for healthcare education and professional development. Bibliometric indicators demonstrate sustained scholarly productivity with 66 indexed publications, more than 1,400 citations, and an h-index of 20, illustrating continuing influence across related research communities.[1]

Keywords

Health Professions, Healthcare Research, Evidence-Based Practice, Academic Collaboration, Clinical Education, Research Innovation, Scholarly Publications, Citation Impact.

Introduction

Innovation within health sciences depends upon the generation of reliable evidence, collaborative investigation, and the translation of research findings into educational and professional settings. Angela Yang’s academic activities contribute to these objectives through consistent scholarly output and participation in internationally indexed research. Her work reflects contemporary approaches to healthcare improvement supported by recognized academic databases and citation metrics.[2]

Research Profile

Affiliated with RMIT University, Angela Yang maintains an active research profile focused on Health Professions. Her publication portfolio demonstrates participation in multidisciplinary projects and peer-reviewed journals indexed by major scholarly databases. The available bibliometric indicators suggest sustained research engagement and growing international academic visibility.[1]

Research Contributions

Development of evidence-based research relevant to Health Professions.Collaboration with multidisciplinary research teams. Publication of scholarly articles in internationally indexed journals. Contribution to knowledge translation supporting healthcare education and practice.[3]

Publications

The research portfolio consists of 66 Scopus-indexed publications that collectively demonstrate continuing academic productivity. These publications have generated substantial scholarly attention and are supported by persistent citation growth. Representative articles include works with registered Digital Object Identifiers (DOIs), ensuring permanent scholarly accessibility, for example: [4]

Research Impact

Citation indicators provide an objective measure of scholarly influence. Angela Yang’s documented citation count of 1,491 and h-index of 20 indicate that her publications have been referenced across multiple studies, reflecting continuing academic relevance and contribution to the advancement of Health Professions research.[1]

Award Suitability

Based on publicly available bibliometric information, Angela Yang demonstrates several characteristics commonly associated with academic recognition, including sustained publication activity, measurable research impact, interdisciplinary collaboration, and contributions to evidence-informed healthcare research. These qualities align with the objectives of the Innovative Research Award, which recognizes scholarly excellence, innovation, and continued advancement of research within professional disciplines.[5]

Conclusion

Angela Yang’s scholarly record reflects consistent academic productivity, meaningful citation performance, and contributions to Health Professions research. Her documented publication history, international visibility, and commitment to evidence-based scholarship provide a well-supported academic profile suitable for recognition through the Innovative Research Award while acknowledging the importance of continued scientific excellence and research integrity.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Angela Yang, Author ID 24598325800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24598325800
  2. ORCID. (n.d.). Angela Yang ORCID Record.
    https://orcid.org/0000-0001-9345-4607
  3. Xu, J., Li, H., Stylianou, S., Sze, D. M.-Y., Chan, V. W. S., & Yang, A. W. H. (2025). Validation of a Qigong quality of life questionnaire (3Q instrument) in patients with cancer: A study protocol. BMJ Open. Advance online publication.
    https://bmjopen.bmj.com/content/15/9/e092973
  4. Li, H., Su, H., Komori, A., Yang, S., Luo, H., Yang, A. W. H., Sun, X., Li, H., Hung, A., & Zhao, X. (2025). Supercomputing multi-ligand modeling, simulation, wavelet analysis and surface plasmon resonance to develop novel combination drugs: A case study of Arbidol and Baicalein against main protease of SARS-CoV-2.
    https://www.mdpi.com/1424-8247/18/7/1054
  5. Xu, J., Li, H., Sze, D. M.-Y., Chan, V. W. S., & Yang, A. W. H. (2025). Effectiveness of qigong and Tai Chi for quality of life in patients with cancer: An umbrella review and meta-analysis. BMC Complementary Medicine and Therapies, 25, Article 4875.
    https://link.springer.com/article/10.1186/s12906-025-04875-1

PHILIPPE LEFF | Health Professions | Lifetime Achievement Award

Published on by Award and Honors

Dr. PHILIPPE LEFF | Health Professions | Lifetime Achievement Award

Medico | INPer | Mexico

Dr. Philippe Leff Gelman is a distinguished medical scientist and neuroscientist from Mexico City with extensive expertise in neurochemistry, neuroendocrinology, and clinical neuroscience, focusing on maternal mental health, addiction neurobiology, and perinatal neuroscience. Fluent in Spanish, English, and proficient in French, he earned his Medical Degree from UNAM, Mexico City, followed by a Master’s in Chemical Sciences (Biochemistry) at UNAM and a Doctorate in Medical Research from Instituto Politécnico Nacional, where he focused on biosynthetic precursors of endomorphin-like peptides. He completed postdoctoral studies in Cell Biology & Anatomy at the University of Miami and Behavioral Neuroscience at Boston University, training in neuronal protein synthesis and animal models of drug self-administration. Dr. Leff Gelman has held senior research positions at Instituto Nacional de Perinatología and Instituto Nacional de Psiquiatría, contributed to vaccine development for opioid addiction, and served as a visiting professor internationally. His research integrates neuroendocrine regulation, maternal behavior, neurodevelopment, and addiction neuroscience, bridging molecular, behavioral, and clinical approaches. He has received multiple national and international awards, reflecting his global impact, mentorship, and sustained scientific leadership.

Profile : Scopus 

Featured Publication 

Dr. Leff Gelman has authored numerous influential publications in international peer-reviewed journals, contributing significantly to neuroendocrinology, perinatal mental health, and addiction neuroscience. Key works include:

Leff-Gelman, P., Pellón-Díaz, G., Camacho-Arroyo, I., Palomera-Garfias, N., & Flores-Ramos, M. Neuroendocrine regulation and neural circuitry of parenthood: Integrating neuropeptides, brain receptors, and maternal behavior. International Journal of Molecular Sciences, 26(18), 9007.

Leff, P., Chinchilla-Ochoa, D., Olivas-Peña, E., Granados-Cepeda, M. L., Trejo-Sánchez, K. C., & Farfán-Labonne, B. E. Cognitive dysfunction in systemic lupus erythematosus during pregnancy. American Journal of Reproductive Immunology, 94(2), e70134.

Camacho-Arroyo, I., Flores-Ramos, M., Mancilla-Herrera, I., Cruz-Coronel, F. M., Farfán-Labonne, B., Jiménez-Aquino, L. E., et al. Alterations in adipokine levels are associated with human perinatal anxiety and depression. Journal of Clinical Medicine, 14(12), 4102.

Meza-Rodríguez, M. D. P., Leff-Gelman, P., et al. Serotonin, cortisol, and DHEA-S levels in anxious and depressive pregnant women living with HIV. BMC Psychology, 12, 563.

 

Shebli Atrash | Health Professions | Best Researcher Award

Published on by Award and Honors

Dr. Shebli Atrash | Health Professions | Best Researcher Award 

Dr. Shebli Atrash | Levine Cancer Institute | United States

Dr. Shebli Atrash, MD, MS, FACP, is a distinguished physician-scientist specializing in hematological malignancies and blood disorders. Currently serving as Associate Professor at Wake Forest University School of Medicine, he is deeply committed to advancing cancer research, patient care, and medical education. With an MD from the University of Damascus and advanced training in cancer biology at the University of Arkansas for Medical Sciences, Dr. Atrash has built a career centered on innovation in oncology. His expertise spans clinical practice, academic teaching, translational research, and leadership in clinical trials. Over the years, he has earned multiple recognitions for excellence, including Resident of the Year and awards for top accrual in clinical trials. As a reviewer and editor for leading journals and an active member of numerous professional societies, he continues to shape the global conversation in oncology. His dedication bridges scientific innovation with compassionate patient care.

Professional Profile: 

Scopus

ORCID

Google Scholar

Education

Dr. Atrash began his medical journey at the University of Damascus, where he earned his MD. His pursuit of deeper scientific knowledge led him to the University of Arkansas for Medical Sciences (UAMS), where he completed a Clinical Translational Science Certificate and a Master of Science in Interdisciplinary Biomedical Sciences with a cancer biology track. To complement his clinical and academic expertise, he also completed advanced leadership training through the Physician/APP Leadership Institute program at Atrium Health Levine Cancer Institute and Wake Forest University School of Medicine. His educational path reflects a balance of rigorous medical training, translational research expertise, and leadership development. Each step has prepared him to excel in bridging bedside care with cutting-edge oncology research. His lifelong learning commitment underscores his passion for improving outcomes for patients with hematologic malignancies.

Experience

Dr. Atrash’s professional journey demonstrates a remarkable blend of clinical excellence, academic leadership, and scientific research. He began his training as an Internal Medicine Intern and Resident at St. Barnabas Hospital/Albert Einstein College of Medicine, followed by a Hematology & Oncology Fellowship at UAMS. His faculty appointments span prestigious institutions, including the University of Arkansas for Medical Sciences, University of North Carolina, Atrium Health, and now Wake Forest University School of Medicine, where he serves as an Associate Professor in Hematology and Oncology. Beyond academia, Dr. Atrash has contributed to clinical trial development, serving on multiple advisory boards for leading pharmaceutical companies and acting as a reviewer and editor for top oncology journals. His wide-reaching experience also includes roles on independent review committees for pivotal Phase  clinical trials. With a career marked by leadership, innovation, and collaboration, Dr. Atrash is recognized as both a skilled clinician and a visionary researcher.

Research Interest

Dr. Atrash’s research interests center on hematological malignancies, with a special focus on multiple myeloma. He is deeply engaged in exploring novel therapies and clinical trials that advance patient care, including CAR-T cell therapy, antibody-drug conjugates, and combination regimens for relapsed/refractory myeloma. His translational work integrates cancer cell biology with therapeutic innovation, seeking to develop strategies that improve survival and quality of life for patients. He is currently the Principal Investigator of a multimillion-dollar investigator-initiated trial exploring Carfilzomib, Lenalidomide, Dexamethasone, and Belantamab Mafodotin for multiple myeloma. Additionally, his roles on the International Myeloma Working Group (IMWG), Southwest Oncology Group (SWOG), and CIBMTR reflect his influence on the global hematology research agenda. His interests also extend to improving clinical trial design, translational oncology, and immune-based therapies, positioning him as a leader in shaping the next generation of cancer therapeutics.

Awards

Dr. Atrash has consistently been recognized for his excellence in medicine, research, and clinical trials. Early in his career, he was honored as Resident of the Year at St. Barnabas Hospital. During his time at the University of Arkansas for Medical Sciences, he received the Dean’s Circle of Excellence Awards, highlighting his academic and clinical contributions. More recently, at Atrium Health, he was recognized as the Top Accruer for interventional and non-interventional clinical trials, showcasing his leadership in clinical research and dedication to advancing therapies for patients. These honors reflect his consistent ability to combine academic rigor, research innovation, and patient-centered care. Collectively, they illustrate a career built on excellence, impact, and recognition from both peers and leading institutions in oncology and internal medicine.

Publications

Dr. Atrash has authored and co-authored numerous impactful publications in top-tier oncology and hematology journals. His research spans multiple myeloma, novel therapeutics, and immune-based strategies, with publications widely cited by peers. He also serves as a reviewer, guest editor, and editorial board member for high-impact journals such as Cancers, British Journal of Haematology, and Annals of Blood. Selected publications include:

Title: Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
Citations: 2

Title: Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
Journal: Blood Cancer Journal, 2025

Title: A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma
Journal: Blood, 2025

Title: Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 Institutes
Journal: Clinical Lymphoma Myeloma and Leukemia, 2025

Title: Teclistamab for patients with heavily pretreated relapsed/refractory multiple myeloma and renal impairment
Journal: Blood Advances, 2025

Title: Global Access to Multiple Myeloma Therapies
Journal: JCO Global Oncology, 2025

Conclusion

Dr. Shebli Atrash is a highly qualified candidate for the Best Researcher Award, bringing together academic excellence, clinical innovation, and impactful service to the hematology and oncology community. His strong record in clinical trial leadership, journal editorships, and advisory roles establishes him as a distinguished researcher in multiple myeloma. With continued growth in authorship leadership, international visibility, and mentorship, Dr. Atrash’s career trajectory promises sustained contributions to cancer research and patient outcomes. Based on his strengths, he is highly suitable for this award.

Ms. Densenbal Dansran | Health Professions | Best Researcher Award

Published on by Award and Honors

Ms. Densenbal Dansran | Health Professions | Best Researcher Award 

School of Medicine | Mongolian National University of Mongolia | Mongolia

Ms. Densenbal Dansran is a practitioner and academician at the Mongolian National University of Medical Sciences, specializing in pulmonology and internal medicine. His career began as a physician in emergency care and internal departments of major hospitals in Ulaanbaatar, after which he transitioned into academia. As a lecturer at the School of Medicine, he has contributed to training future physicians while actively engaging in clinical research. His work has centered on respiratory health, with a strong focus on occupational exposure and pulmonary diseases. He has published and presented widely, particularly on issues such as silicosis, asthma, lung cancer, and allergic respiratory conditions. Through his participation in national and international research collaborations, he has become a key figure in advancing medical knowledge in Mongolia, raising awareness about public health challenges, and advocating for better occupational health standards.

Profile

Scopus

Education

Ms. Densenbal Dansran holds a strong multidisciplinary educational foundation that has supported his dual career as a clinician and academic. He completed his Bachelor of Medicine at the Health Science University of Mongolia, gaining a solid background in medical sciences and clinical practice. Later, he broadened his expertise by completing a Bachelor of Linguistics (English) at Humanity University, which enabled him to communicate effectively with international research communities. He pursued a Master’s degree in Medical Sciences at the Mongolian National University of Medical Sciences, specializing in internal medicine and pulmonology. His advanced training provided the necessary expertise to investigate respiratory diseases and occupational hazards affecting the Mongolian population. This academic progression not only prepared him for a career in healthcare and education but also positioned him to collaborate in international research projects and present findings at global medical conferences.

Experience

Ms. Densenbal Dansran has accumulated extensive professional experience across multiple domains of medicine. His early career began as a general doctor in emergency medical centers, where he provided critical care to patients in acute conditions. He later worked in the emergency and outpatient departments of the Second General Hospital, focusing on internal medicine and pulmonary health. He served as a pulmonologist in outpatient departments and contributed as a contract medical doctor at The State Second Hospital and the P. Shastin State Third Hospital. His long-standing academic role as a lecturer at the Mongolian National University of Medical Sciences, School of Medicine, in the Department of Pulmonology and Allergology, has been equally impactful. In this capacity, he has guided students, trained medical practitioners, and contributed to public health awareness. His clinical and teaching roles demonstrate a commitment to patient care, medical education, and research excellence.

Research Interests

Ms. Densenbal Dansran’s research focuses on pulmonary health, occupational exposure, and respiratory diseases. He has conducted field studies on artisanal and small-scale gold miners in Mongolia, highlighting the risks of silicosis, heavy metal exposure, and other respiratory problems caused by dust inhalation. His research also extends to the respiratory effects of industrial pollution, where he has studied asthma, allergic rhinitis, and chronic lung conditions in urban populations. In addition, he has examined cardiovascular risks in patients with chronic respiratory diseases and explored inflammatory indicators in smokers. His collaboration with international research foundations has strengthened his capacity to address occupational and environmental health risks. His work is characterized by its applied nature, connecting clinical observation with public health initiatives, and contributing to preventive strategies for respiratory illnesses. These research interests position him as a leader in pulmonology and occupational health studies in Mongolia.

Awards and Recognitions

Although formal honors remain limited, Densenbal Dansran has achieved significant recognition through his research contributions and international collaborations. He has been awarded competitive research grants from international foundations, which have supported his projects on respiratory health and occupational exposure in Mongolia. His work has been showcased at major international conferences, including the Asia-Pacific Society of Respirology and the Union World Conference on Lung Health, where he presented findings on silicosis, allergic rhinitis, asthma, and respiratory symptoms in industrial regions. His recognition extends beyond funding and conference participation, as his studies have also contributed to raising awareness of respiratory health issues among vulnerable populations. These achievements reflect his academic credibility, dedication to research, and contributions to improving occupational and environmental health standards in Mongolia. His efforts highlight his ability to bring national health challenges to international attention and foster meaningful solutions.

Publications

Ms. Densenbal Dansran has authored research studies and presented at conferences on respiratory health and occupational medicine. His publications and presentations include: